Genmab — Juli 2017
-
Transcript fra J&J Q2 conference call - https://www.google.dk/amp/s/seekingalpha.com/amp/article/4088491-johnson-and-johnsons-jnj-ceo-alex-gorsky-q2-2017-results-earnings-call-transcript
-
God morgen.
-
Recepttal?
-
Det stemmer ikke rigtigt med vores udregninger i går.
-
-
Rachel svarede flg omkring JJ act revenue og symphony prescription data: Afraid I cannot comment on your assumptions. The symphony data should come tomorrow which is public for the market. We have our Q2 on August 9.
Perhaps most important to stress is that we do not focus month on month but Q on Q and we are very happy with the launch and the growing sales. We are still on track for our guidance.
-
jep - tallene var identiske
-
i Q2 hedder symphony usd 233,1m og JJ reelle omsætning usd 212m = en uforklaret difference på usd 21,1m.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind